CN106164256B - 来自脐带血的汇集的nk细胞和在治疗癌和慢性感染病中的应用 - Google Patents

来自脐带血的汇集的nk细胞和在治疗癌和慢性感染病中的应用 Download PDF

Info

Publication number
CN106164256B
CN106164256B CN201580011900.9A CN201580011900A CN106164256B CN 106164256 B CN106164256 B CN 106164256B CN 201580011900 A CN201580011900 A CN 201580011900A CN 106164256 B CN106164256 B CN 106164256B
Authority
CN
China
Prior art keywords
cells
cell
hla
ucb
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580011900.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN106164256A (zh
Inventor
P·埃诺
M·比利亚尔瓦·冈萨雷斯
陆朝阳
J·F·罗西
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ai Mel
National Medical And Health Research Institute
Centre Hospitalier Universitaire de Montpellier
Universite de Montpellier
Original Assignee
Emercell Sas
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Universitaire de Montpellier
Universite de Montpellier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emercell Sas, Institut National de la Sante et de la Recherche Medicale INSERM, Centre Hospitalier Universitaire de Montpellier, Universite de Montpellier filed Critical Emercell Sas
Publication of CN106164256A publication Critical patent/CN106164256A/zh
Application granted granted Critical
Publication of CN106164256B publication Critical patent/CN106164256B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
    • A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/15—Natural-killer [NK] cells; Natural-killer T [NKT] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2302—Interleukin-2 (IL-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2315—Interleukin-15 (IL-15)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Dentistry (AREA)
  • Oncology (AREA)
  • Environmental Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Virology (AREA)
CN201580011900.9A 2014-03-07 2015-03-09 来自脐带血的汇集的nk细胞和在治疗癌和慢性感染病中的应用 Active CN106164256B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14305332.0 2014-03-07
EP14305332 2014-03-07
PCT/EP2015/054837 WO2015132415A1 (en) 2014-03-07 2015-03-09 Pooled nk cells from ombilical cord blood and their uses for the treatment of cancer and chronic infectious disease

Publications (2)

Publication Number Publication Date
CN106164256A CN106164256A (zh) 2016-11-23
CN106164256B true CN106164256B (zh) 2021-08-10

Family

ID=50277168

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580011900.9A Active CN106164256B (zh) 2014-03-07 2015-03-09 来自脐带血的汇集的nk细胞和在治疗癌和慢性感染病中的应用

Country Status (8)

Country Link
US (1) US20170073637A1 (enExample)
EP (1) EP3114215B1 (enExample)
JP (2) JP6775426B2 (enExample)
CN (1) CN106164256B (enExample)
CA (1) CA2941519C (enExample)
DK (1) DK3114215T3 (enExample)
ES (1) ES2880718T3 (enExample)
WO (1) WO2015132415A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017042393A1 (en) * 2015-09-11 2017-03-16 Emercell Sas Pooled nk cells from umbilical cord blood associated with antibodies and their uses for the treatment of disease
KR20180086204A (ko) * 2015-11-05 2018-07-30 글리코스템 떼라퓨틱스 비.브이. 면역치료법에 사용하기 위한 조성물
EP3411414A4 (en) * 2016-02-05 2019-10-23 Washington University COMPOSITIONS AND METHOD FOR TARGETED CYTOKINE RELIEF
EP3746095A4 (en) 2018-02-01 2021-04-21 Nkmax Co., Ltd. Method of producing natural killer cells and composition for treating cancer
EP3755349A4 (en) 2018-02-21 2021-11-17 Board of Regents, The University of Texas System PROCESS FOR ACTIVATION AND EXPANSION OF NATURAL KILLER CELLS AND THEIR USES
DK3755347T3 (da) * 2018-02-21 2025-08-04 Univ Texas Universelle antigenpræsenterende celler og anvendelser deraf
KR20210052494A (ko) 2018-08-27 2021-05-10 아피메트 게엠베하 항체 구조물이 사전 로드된 동결 보존된 nk 세포
WO2020152661A1 (ja) * 2019-01-21 2020-07-30 株式会社ガイアバイオメディシン Ｎｋ細胞を含む細胞集団の製造方法
JP6838750B2 (ja) * 2019-01-21 2021-03-03 株式会社ガイアバイオメディシン Ｎｋ細胞を含む細胞集団の製造方法
JP6977969B2 (ja) * 2019-03-22 2021-12-08 株式会社ガイアバイオメディシン 免疫細胞提供システム
JP2021035400A (ja) * 2020-12-07 2021-03-04 株式会社ガイアバイオメディシン Ｎｋ細胞を含む細胞集団の製造方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2703428A1 (en) * 2010-05-11 2011-11-11 Mcgill University Health Center Pooled cord blood units
CN102356154A (zh) * 2008-10-24 2012-02-15 株式会社美迪赛 从脐带血有效增殖和分化自然杀伤细胞的方法
WO2012118349A2 (ko) * 2011-03-03 2012-09-07 한국생명공학연구원 제대혈 ｃｄ14 양성 단핵세포로부터 자연살해세포 분화 및 증식 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012009422A1 (en) * 2010-07-13 2012-01-19 Anthrogenesis Corporation Methods of generating natural killer cells
WO2012146702A1 (en) * 2011-04-28 2012-11-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for preparing accessory cells and uses thereof for preparing activated nk cells
JP5840876B2 (ja) * 2011-06-24 2016-01-06 テラ株式会社 Ｎｋ細胞を増幅するための組成物及び方法
JP5572863B2 (ja) * 2011-06-24 2014-08-20 国立大学法人九州大学 Ｎｋ細胞の増幅方法
WO2014123879A1 (en) * 2013-02-05 2014-08-14 Anthrogenesis Corporation Natural killer cells from placenta

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102356154A (zh) * 2008-10-24 2012-02-15 株式会社美迪赛 从脐带血有效增殖和分化自然杀伤细胞的方法
CA2703428A1 (en) * 2010-05-11 2011-11-11 Mcgill University Health Center Pooled cord blood units
WO2011140654A1 (en) * 2010-05-11 2011-11-17 Mcgill University Health Center Pooled cord blood units
WO2012118349A2 (ko) * 2011-03-03 2012-09-07 한국생명공학연구원 제대혈 ｃｄ14 양성 단핵세포로부터 자연살해세포 분화 및 증식 방법

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults;Meghan Delaney et al.,;《TRANSFUSION》;20090531;第49卷;995-1002 *
Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts;Sharon Avery et al.,;《BLOOD》;20110324;第117卷(第12期);3277-3285 *
Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia;T-H Jaing et al.,;《Bone Marrow Transplantation》;20071231;第40卷;307-311 *

Also Published As

Publication number Publication date
ES2880718T3 (es) 2021-11-25
CA2941519C (en) 2022-09-06
DK3114215T3 (da) 2021-06-21
JP2017508479A (ja) 2017-03-30
US20170073637A1 (en) 2017-03-16
WO2015132415A1 (en) 2015-09-11
CN106164256A (zh) 2016-11-23
EP3114215A1 (en) 2017-01-11
JP6775426B2 (ja) 2020-10-28
JP2020114248A (ja) 2020-07-30
CA2941519A1 (en) 2015-09-11
EP3114215B1 (en) 2021-04-14

Similar Documents

Publication Publication Date Title
CN106164256B (zh) 来自脐带血的汇集的nk细胞和在治疗癌和慢性感染病中的应用
US9404083B2 (en) Method for amplifying NK cells
US12329817B2 (en) Highly active NK cell and use thereof
EP3000876B1 (en) Method for preparing nk cells
CN107002039A (zh) 使用t细胞用于培养自然杀伤细胞的方法
JP6073417B2 (ja) 自然殺害細胞増殖方法、及び自然殺害細胞増殖用の組成物
JP5989016B2 (ja) Ｎｋ細胞の増幅方法
TWI757709B (zh) 含有nk細胞之細胞集團之製造方法
KR20120054018A (ko) 일과성 생착 ｃｔｌ을 포함하는 의약품 조성물
Jin et al. The CD56bright CD62L+ NKG2A+ immature cell subset is dominantly expanded in human cytokine-induced memory-like NK cells
JP2023153286A (ja) Ｎｋ細胞を含む細胞集団の製造方法
HK1190432B (en) Method for amplifying nk cells
HK1171949A (en) Pharmaceutical composition containing transiently surviving ctl

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20181122

Address after: Saint Matieu de Trevier, France

Applicant after: AI, Mel.

Applicant after: National Medical and Health Research Institute

Applicant after: CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER

Applicant after: Universite De Montpellier

Address before: Saint Matieu de Trevier, France

Applicant before: AI, Mel.

Applicant before: National Medical and Health Research Institute

TA01 Transfer of patent application right
CB03 Change of inventor or designer information

Inventor after: P.Aino

Inventor after: M*Gonzales Villalba

Inventor after: Lu Chaoyang

Inventor after: J.F.Rossi

Inventor before: P.Aino

Inventor before: M*Gonzales Villalba

CB03 Change of inventor or designer information
GR01 Patent grant
GR01 Patent grant